Loss of PTEN expression was detected specifically in metastatic breast cancer cells in the brain, not in those in other organs, as a result of epigenetic regulation by miRNAs derived from astrocytes [41] (Fig. 1b(k)). The gene discussed is PTEN; the disease is breast carcinoma.